Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological ...

Milestone Scientific Inc (MLSS) reports stable revenue with significant operating expense reductions and strategic ...

Bionano Genomics, Inc. (NASDAQ: BNGO) Q3 2025 Earnings Call Transcript November 13, 2025 Bionano Genomics, Inc. beats ...

First full post acquisition quarter builds momentum for 2026 (Dignitana has been part of the group since June 1. Figures in parentheses refer to the outcome for the corresponding period of the previou ...

BOSTON, Nov. 14, 2025 /PRNewswire/ -- Intrinsic Therapeutics, Inc., the makers of the Barricaid (R) Bone-Anchored Annular Closure Device, announced today the first endoscopic Barricaid implantation in ...

Medical coding can be a real headache, right? It’s complicated, time-consuming, and honestly, prone to errors when ...

Omeros Corp (OMER) navigates financial hurdles with a promising Novo Nordisk deal and prepares for a pivotal drug launch.

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 27 years, gives his ...

REGULATED INFORMATION Nyxoah Reports Third Quarter 2025 Financial and Operating Results US launch off to a strong start. First commercial Genio implants completed with widespread payer coverage drives ...

Last-minute advocacy by the AOA and other physician groups secured the 2.5% pay increase in H.R. 1, reversing the expected ...

SALT LAKE CITY, Nov. 13, 2025 /PRNewswire/ — Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker ...

Corneal crosslinking failure rates were low in a US registry analysis, but CXL failure risk was doubled for patients aged younger than 18 years.